Research

Research

Assessing Clinical and Economic Value


PMC studies the clinical and economic value of personalized health care approaches across a broad range of disease states.


2022




“Cost-Effectiveness of Exome and Genome Sequencing for Children With Rare and Undiagnosed Conditions,” Genetics in Medicine


2020




"Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer," Clinical Lung Cancer


2019




"Cost Effectiveness of Multigene Panel Sequencing for Patients
With Advanced Non–Small-Cell
Lung Cancer," JCO Clinical
Cancer Informatics







"One Size Does Not Always Fit All in Value Assessment," American Journal of Managed Care

2017




Personalized Medicine and Value Assessment Frameworks: Context, Considerations, and Next Steps


Research Lead


Daryl Pritchard, Ph.D., Senior Vice President, Science Policy


Research Assistant


Lindsay Stephens, Program Manager & Secretary to the Board